These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 31032274)

  • 1. Efficacy and safety of Shen-Yuan-Dan capsules for peri-procedural myocardial injury following percutaneous coronary intervention: study protocol for a randomized, double-blind, placebo-controlled trial.
    Li X; Lai XL; Fei YT; Shang JJ; Zhou Q; Sun XY; Xing WL; Jia SH; Liu HX
    Ann Transl Med; 2019 Mar; 7(6):119. PubMed ID: 31032274
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A randomized, placebo-controlled, double-blind trial to evaluate efficacy and safety of Shen-Yuan-Dan capsules, a traditional Chinese medicine, for treatment of peri-procedure myocardial injury following percutaneous coronary intervention.
    Li X; Zhang Y; Liu HX; Shang JJ; Zhou Q; Li AY; Lai XL; Xing WL; Jia SH
    Complement Ther Med; 2022 Oct; 69():102841. PubMed ID: 35643381
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of Shen-Yuan-Dan on Periprocedural Myocardial Injury and the Number of Peripheral Blood Endothelial Progenitor Cells in Patients with Unstable Angina Pectoris Undergoing Elective Percutaneous Coronary Intervention.
    Zhang Z; Xing W; Liu H; Zhou Q; Liu X; Shang J
    Evid Based Complement Alternat Med; 2022; 2022():9055585. PubMed ID: 35035512
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical Characteristics and Risk Factors of Periprocedural Myocardial Injury in Patients with Elective PCI in a TCM Hospital.
    Li X; Zhang HY; Shang JJ; Liu HX; Zhou Q; Lai XL
    Evid Based Complement Alternat Med; 2022; 2022():7158740. PubMed ID: 35368758
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of Xinyue capsules on patients with coronary heart disease after percutaneous coronary intervention: study protocol for a randomized controlled trial.
    Guo M; Zi MJ; Xi RX; Yang QN; Bai RN; Zhang YS; Wang YH; Wang PL; Shi DZ
    Trials; 2016 Aug; 17():412. PubMed ID: 27538952
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design and Rationale for the Endothelin-1 Receptor Antagonism in the Prevention of Microvascular Injury in Patients with non-ST Elevation Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention (ENDORA-PCI) Trial.
    Liou K; Jepson N; Buckley N; Chen V; Thomas S; Russell EA; Ooi SY
    Cardiovasc Drugs Ther; 2016 Apr; 30(2):169-75. PubMed ID: 26814686
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of Danlou Tablet () on peri-procedural myocardial injury among patients undergoing percutaneous coronary intervention for non-ST elevation acute coronary syndrome: A study protocol of a multicenter, randomized, controlled trial.
    Wang L; Mao S; Qi JY; Ren Y; Guo XF; Chen KJ; Zhang MZ
    Chin J Integr Med; 2015 Sep; 21(9):662-6. PubMed ID: 26142341
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Study Protocol for a Randomized, Double-Blind, Placebo-Controlled Clinical Study on the Effect of Qishen Yiqi Dripping Pills on Exercise Endurance and Quality of Life in Patients with Coronary Heart Disease after Percutaneous Coronary Intervention.
    Yu L; Lu X; Li X; Jiang H; Sun R; Chen G; Xiao C
    Evid Based Complement Alternat Med; 2021; 2021():7439852. PubMed ID: 34475964
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of Peri-Procedural Myocardial Infarction on Outcomes After Revascularization.
    Hara H; Serruys PW; Takahashi K; Kawashima H; Ono M; Gao C; Wang R; Mohr FW; Holmes DR; Davierwala PM; Head SJ; Thuijs DJFM; Milojevic M; Kappetein AP; Garg S; Onuma Y; Mack MJ;
    J Am Coll Cardiol; 2020 Oct; 76(14):1622-1639. PubMed ID: 33004127
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of Sodium Tanshinone IIA Sulfonate in Patients with Non-ST Elevation Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention: Results from a Multicentre, Controlled, Randomized Trial.
    Mao S; Wang L; Zhao X; Guo L; Lin Q; Wang X; Dai X; Shang H; Zhang M; Hinek A
    Cardiovasc Drugs Ther; 2021 Apr; 35(2):321-329. PubMed ID: 32940893
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Implications of Alternative Definitions of Peri-Procedural Myocardial Infarction After Coronary Revascularization.
    Gregson J; Stone GW; Ben-Yehuda O; Redfors B; Kandzari DE; Morice MC; Leon MB; Kosmidou I; Lembo NJ; Brown WM; Karmpaliotis D; Banning AP; Pomar J; Sabaté M; Simonton CA; Dressler O; Kappetein AP; Sabik JF; Serruys PW; Pocock SJ
    J Am Coll Cardiol; 2020 Oct; 76(14):1609-1621. PubMed ID: 33004126
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of trimetazidine on ventricular remodeling in coronary artery disease patients with left ventricular hypertrophy: the rationale and design of a randomized controlled trial.
    Wu L; Luan Y; Li Y; Wang M; He J; Jin C; Zhang W
    BMC Cardiovasc Disord; 2020 Jun; 20(1):273. PubMed ID: 32503494
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The efficacy and safety of Chinese herbal medicine Shen-Qi Hua-Yu formula in patients with diabetic lower extremity artery disease: Study protocol of a multi-center, randomized, double-blind, placebo-controlled trial.
    Leng Y; Gao H; Fu X; Xie H; Hu Z; Zhu J; Liu X; Zhou X; Xie Z; Xie C
    Medicine (Baltimore); 2020 Jan; 99(3):e18713. PubMed ID: 32011447
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of Danhong Injection () on Peri-Procedural Myocardial Injury and Microcirculatory Resistance in Patients with Unstable Angina Undergoing Elective Percutaneous Coronary Intervention: A Pilot Randomized Study.
    Xing WL; Wu YJ; Liu HX; Liu QR; Zhou Q; Li AY; Zhang ZH; Li X
    Chin J Integr Med; 2021 Nov; 27(11):846-853. PubMed ID: 34263442
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of naotaifang capsules for hypertensive cerebral small vessel disease: Study protocol for a multicenter, randomized, double-blind, placebo-controlled clinical trial.
    Fang R; Hu H; Zhou Y; Wang S; Mei Z; She R; Peng X; Jiang Q; Wang X; Xie L; Lin H; Meng P; Zhang K; Wang W; Xie Y; Liu L; Tong J; Wu D; Luo Y; Liu C; Lu Y; Yu S; Cheng S; Xu L; Fang Z; Shang H; Ge J
    Front Pharmacol; 2022; 13():967457. PubMed ID: 36686705
    [No Abstract]   [Full Text] [Related]  

  • 16. Effects on Suxiao Jiuxin Pills in the Treatment of Patients with Acute Coronary Syndrome Undergoing Early Percutaneous Coronary Intervention: A Multicenter Randomized Double-Blind Placebo-Controlled Trial.
    Shen Z; Chen T; Deng B; Fan M; Hua J; Zhang M; Wang X
    J Altern Complement Med; 2020 Nov; 26(11):1055-1063. PubMed ID: 32716206
    [No Abstract]   [Full Text] [Related]  

  • 17. The role of Glucagon-Like Peptide 1 Loading on periprocedural myocardial infarction During elective PCI (GOLD-PCI study): A randomized, placebo-controlled trial.
    Giblett JP; Clarke S; Zhao T; McCormick LM; Braganza DM; Densem CG; O'Sullivan M; Adlam D; Clarke SC; Steele J; Fielding S; West NEJ; Villar SS; Hoole SP
    Am Heart J; 2019 Sep; 215():41-51. PubMed ID: 31277053
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association Between Lipoprotein(a) and Peri-procedural Myocardial Infarction in Patients With Diabetes Mellitus Who Underwent Percutaneous Coronary Intervention.
    Liu Y; Wang W; Song J; Zhang K; Xu B; Li P; Shao C; Yang M; Chen J; Tang YD
    Front Endocrinol (Lausanne); 2020; 11():603922. PubMed ID: 33613445
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of liposomal prostaglandin E1 on periprocedural myocardial injury in patients with unstable angina undergoing an elective percutaneous coronary intervention.
    Fan Y; Jiang Y; Fu X; Cai J; Wang Y; Li W; Gu X; Xing K; Bai S; Bi X
    Coron Artery Dis; 2015 Dec; 26(8):671-7. PubMed ID: 26267747
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High dose statin loading prior to percutaneous coronary intervention decreases cardiovascular events: a meta-analysis of randomized controlled trials.
    Benjo AM; El-Hayek GE; Messerli F; DiNicolantonio JJ; Hong MK; Aziz EF; Herzog E; Tamis-Holland JE
    Catheter Cardiovasc Interv; 2015 Jan; 85(1):53-60. PubMed ID: 24272891
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.